US approves new HIV drug
The US Food and Drug Administration on Friday approved a new drug, Edurant, to fight HIV in combination with other antiretrovirals already on the market.
May 21, 2011
not rated yet
0
May 21, 2011
not rated yet
0
Common treatments for children with HIV equally effective, study shows
(PhysOrg.com) -- A major trial comparing the effectiveness of two classes of drugs commonly used to treat HIV in children has found that both are equally effective as an initial treatment. The study, published online today ...
Feb 01, 2011
not rated yet
0
HIV drug that protects a fetus should be avoided for one year after childbirth, researchers say
Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the ...
Feb 26, 2010
not rated yet
0
Researchers present Phase II HIV gene therapy trial data at CROI 2010
In the study, seven of eight subjects experienced a decrease in viral load set point and one subject experienced prolonged, complete control of HIV viremia for more than 14 weeks in the absence of HAART. The study looked ...
Feb 19, 2010
5 / 5 (1)
0
HIV drug resistance lasts about one year in women treated with nevirapine to prevent infant infection
A new international study reported in PLoS Medicine confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infant ...
Feb 16, 2010
not rated yet
0
Research shows treating HIV-AIDS with interleukin-2 is ineffective
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped. Their finding was published ...
Oct 15, 2009
5 / 5 (1)
0
Study highlights HIV/AIDS challenge in American prison system
HIV/Aids is up to five times more prevalent in American prisons than in the general population. Adherence to treatment programs can be strictly monitored in prison. However, once prisoners are released, medical monitoring ...
Sep 29, 2009
5 / 5 (1)
0
Nurses in Africa know when to start antiretroviral treatment
Nurses and clinical officers (non-physician clinicians, NPCs) are capable of determining when a person should receive antiretroviral therapy (ART) for HIV/AIDS. Researchers writing in BioMed Central's open access journal ...
Aug 19, 2009
not rated yet
0
AIDS patients with serious complications benefit from early retroviral use, study shows
HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according ...
May 16, 2009
not rated yet
0
